Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Debt to Equity (2021 - 2024)

Historic Debt to Equity for Biofrontera (BFRI) over the last 4 years, with Q2 2024 value amounting to $0.03.

  • Biofrontera's Debt to Equity changed N/A to $0.03 in Q2 2024 from the same period last year, while for Jun 2024 it was $0.03, marking a year-over-year change of. This contributed to the annual value of $0.81 for FY2023, which is 18016.62% up from last year.
  • Per Biofrontera's latest filing, its Debt to Equity stood at $0.03 for Q2 2024.
  • Over the past 5 years, Biofrontera's Debt to Equity peaked at $6.95 during Q3 2023, and registered a low of -$0.43 during Q1 2024.
  • Moreover, its 4-year median value for Debt to Equity was $0.29 (2021), whereas its average is $1.06.
  • Its Debt to Equity has fluctuated over the past 5 years, first skyrocketed by 474169.56% in 2023, then crashed by 20357.96% in 2024.
  • Over the past 4 years, Biofrontera's Debt to Equity (Quarter) stood at $0.29 in 2021, then rose by 1.67% to $0.29 in 2022, then surged by 180.17% to $0.81 in 2023, then tumbled by 96.67% to $0.03 in 2024.
  • Its Debt to Equity was $0.03 in Q2 2024, compared to -$0.43 in Q1 2024 and $0.81 in Q4 2023.